CF
Cecilia Furlong Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Medtronic
MDT
$119B
| $92.85 | $107 |
15%
upside
| Overweight | 1 month ago |
|
2
iRhythm Technologies
IRTC
$5.85B
| $182.17 | $147 |
19%
downside
| Overweight | 1 month ago |
|
3
Zimmer Biomet
ZBH
$20.8B
| $104.76 | $95 |
9%
downside
| Equal-Weight | 4 months ago |
|
4
Intuitive Surgical
ISRG
$163B
| $454.52 | $650 |
43%
upside
| Overweight | 9 months ago |
|
5
Embecta
EMBC
$847M
| $14.49 | $12 |
17%
downside
| Underweight | 1 year ago |
|
6
Transmedics
TMDX
$3.55B
| $104.05 | $95 |
9%
downside
| Equal-Weight | 1 year ago |
|
7
Alcon
ALC
$39B
| $78.91 | $85 |
8%
upside
| Equal-Weight | 2 years ago |
|
8
Artivion
AORT
$2.08B
| $44.03 | $15 |
66%
downside
| Equal-Weight | 2 years ago |
|
9
Insulet
PODD
$24.4B
| $346.47 | $343 |
1%
downside
| Equal-Weight | 2 years ago |
|
10
Baxter International
BAX
$12.1B
| $23.58 | $48 |
104%
upside
| Equal-Weight | 2 years ago |
|
11
Edwards Lifesciences
EW
$47.5B
| $80.96 | $102 |
26%
upside
| Overweight | 2 years ago |
|
12
Boston Scientific
BSX
$159B
| $107.29 | $58 |
46%
downside
| Overweight | 2 years ago |
|
13
Bausch + Lomb
BLCO
$5.16B
| $14.59 | $20 |
37%
upside
| Equal-Weight | 2 years ago |
|
14
DexCom
DXCM
$31.7B
| $80.76 | $131 |
62%
upside
| Equal-Weight | 2 years ago |
|
15
Abbott
ABT
$231B
| $132.81 | $133 |
0%
upside
| Overweight | 2 years ago |
|
16
Stryker
SYK
$151B
| $394.34 | $220 |
44%
downside
| Equal-Weight | 3 years ago |
|
17
Teleflex
TFX
$5.7B
| $129.09 | $378 |
193%
upside
| Equal-Weight | 3 years ago |
|